Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mucus secretion in the respiratory tract is a vital, highly regulated physiological process central to airway defense. Airway secretory epithelial cells, including goblet cells and submucosal gland cells, synthesize and secrete highly glycosylated, gel-forming mucin glycoproteins, primarily MUC5AC and MUC5B[1][5]. These mucins form the viscoelastic mucus layer that traps and enables the removal of inhaled pathogens, particles, and toxins through mucociliary clearance[3][4][5]. The secretion of mucins involves regulated exocytosis, coordinated by SNARE proteins (such as VAMP8, SNAP23), Munc proteins, MARCKS, and cytoskeletal elements, and is tightly controlled by intracellular calcium signaling[1][2][3]. Pathological increases in mucus secretion (hypersecretion) contribute to diseases such as asthma, COPD, and cystic fibrosis by obstructing airways and impairing clearance[3][4][5].
Mucolytic action (breaking down mucin polymers to reduce viscosity) - Inhibition of secretion (anticholinergics reduce glandular secretion)
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mucus secretion in respiratory tract.